New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Evoke Pharma, Inc.
EVOK
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 May 2025

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 May 2025

2.82USD

Shape0.02 ( 0.57%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

463%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated March 23, 2025
1W -19.20 % 1M -41.74 % 3M -42.45 % 1Y -60.17 %

Key Metrics

Shape
  • Market Cap

    4.21M


  • Shares Outstanding

    1.49M


  • Share in Float

    1.42M


  • Dividende

    0


  • Earning Date

    12 May 2025


  • Price Target

    2.82


  • Average Volume

    16813


  • Beta

    0.116


  • Range

    2.5-12.32


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.evokepharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

EVOK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$20M

Shape505%

2025-Revenue

$0.48

Shape156%

2025-EPS

$18M

Shape-1590%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-8.04
vs -10.09

Q2.23

arrow
arrow

N/A

-6.72
vs -8.52

Q3.23

arrow
arrow

N/A

-6.12
vs -7.20

Q4.23

arrow
arrow

N/A

-7.08
vs -6.36

Q1.24

arrow
arrow

N/A

-2.04
vs -8.04

Q2.24

arrow
arrow

N/A

-0.93
vs -6.72

Q3.24

arrow
arrow

N/A

-0.94
vs -6.12

Q4.24

arrow
arrow

N/A

NA
vs -7.08

Q1.25

arrow
arrow

N/A

-0.33
vs -2.04

Q2.25

arrow
arrow

N/A

-0.23
vs -0.93

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+94%

810.4K  vs 418.4K

Q2.23

arrow
arrow

+145%

1.1M  vs 461.8K

Q3.23

arrow
arrow

+88%

1.6M  vs 832.1K

Q4.23

arrow
arrow

+110%

1.7M  vs 796.4K

Q1.24

arrow
arrow

+114%

1.7M  vs 810.4K

Q2.24

arrow
arrow

+126%

2.6M  vs 1.1M

Q3.24

arrow
arrow

+70%

2.7M  vs 1.6M

Q4.24

arrow
arrow

+97%

3.3M  vs 1.7M

Q1.25

arrow
arrow

+91%

3.3M  vs 1.7M

Q2.25

arrow
arrow

+49%

3.8M  vs 2.6M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-115%

-1.15
vs -0.43

Q2.23

arrow
arrow

-347%

-3.47
vs -1.15

Q3.23

arrow
arrow

+194%

1.94
vs -3.47

Q4.23

arrow
arrow

+77%

0.77
vs 1.94

Q1.24

arrow
arrow

-45%

-0.45
vs 0.77

Q2.24

arrow
arrow

-48%

-0.48
vs -0.45

Q3.24

arrow
arrow

-30%

-0.30
vs -0.48

Q4.24

arrow
arrow

-17%

-0.17
vs -0.30

Institutionnal OwnershipShape

status-upQoQ

Q2.20

arrow
arrow

17

17
vs 15

13%

Q3.20

arrow
arrow

27

27
vs 17

59%

Q4.20

arrow
arrow

32

32
vs 27

19%

Q1.21

arrow
arrow

29

29
vs 32

-9%

Q2.21

arrow
arrow

22

22
vs 29

-24%

Q3.21

arrow
arrow

22

22
vs 22

NA

Q4.21

arrow
arrow

23

23
vs 22

5%

Q1.22

arrow
arrow

18

18
vs 23

-22%

Earnings Growth

Latest News